MedTrace Logo

Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation.

NCT04003337 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2020-05-20

No results posted yet for this study

Summary

Our study intends to demonstrate that the selection of an embryo to transfer it at the sage of blastocyst through morphokinetics (analysis of embryos depending not only in their morphology -that is, the aspect of the embryo-, but also based on times of cell division) during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as selection is not performed in mere morphological evolution (visual aspect of the embryo) of the embryos.

Conditions

  • Embryo Implantation

Interventions

OTHER

Morpho-kinetics selection with time-lapse (Embryoscope) evaluation

Embryos in group B will be selected in blastocyst stage according to morpho-kinetics criteria before the embryo transfer

Sponsors & Collaborators

  • Sociedad Espanola Fertilidad

    collaborator OTHER

  • Procreatec

    lead OTHER

Principal Investigators

  • Lourdes Lopez · Procreatec

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-26
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04003337 on ClinicalTrials.gov